Navigation Links
Pro-Dex, Inc. Announces Fiscal Second Quarter And Six-Month Results
Date:1/10/2013

ations for two weeks during the quarter for the Thanksgiving, Christmas and New Year holidays as part of our cost reduction program.  Our backlog is strong for the second half of fiscal 2013.  We expect to continue to press down on our cost structure while increasing engineering resources.  We expect the programs and projects that we have begun to move our company forward and to build value for every shareholder."

"Of course," Mr. Berthelot noted, "we appreciate the support of each and every shareholder as we pursue our strategy amidst the distraction and diversion of resources due to the contested election of directors.  We understand that there have been some logistical problems in our proxy materials arriving to our shareholders on the West Coast.  If you have not yet received the Company's proxy materials which include the BLUE proxy card, we encourage you to contact our proxy solicitor, AST Phoenix Advisers, at 1-866-721-1318 and ask for the materials to be sent to you.  We ask that all of our shareholders vote for the Pro-Dex director nominees using the BLUE proxy card as quickly as possible, and we thank you for your support."

Teleconference Information:Investors and analysts are invited to listen to a broadcast review of the Company's fiscal 2013 second quarter and six-month financial results today at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) that may be accessed by visiting the Company's website at www.pro-dex.com.  The conference call may also be accessed at www.InvestorCalendar.com. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S. or Canada.

For those who cannot access the live broadcast, a replay will be available approximately two hours after the completion of the call until midnight (Ea
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2013 First Quarter Results
2. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter And Full-Year Results
3. Pro-Dex, Inc. Announces Fiscal 2012 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
4. Pro-Dex, Inc. Announces Update Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
6. Pro-Dex, Inc. Announces Fiscal 2012 Third Quarter Financial Results Conference Call and Webcast
7. Pro-Dex, Inc. Appoints Michael J. Berthelot Chief Executive Officer
8. Amgen Announces 31 Percent Increase In 2013 First Quarter Dividend And Increase In Its Share Repurchase Authorization
9. Accelr8 Announces Results of 2012 Annual Meeting
10. OncoSec Medical Announces $7.2 Million Public Offering
11. Isis Announces That ISIS-TTR Rx Was Granted Fast Track Designation For The Treatment Of Patients With FAP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015 According to a ... Product, Diagnostic (PSG, Pulse Oximeter), Therapeutic [CPAP, APAP, BPAP, ... End User (Home Care Settings, Hospitals) - Analysis & ... studies the global Sleep Apnea Devices Market for the ... expected to reach $5.3 Billion by 2020 from $3.7 ...
(Date:7/29/2015)... July 29, 2015  Cryoport, Inc. (NASDAQ: ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, announced today that the ... stock and warrants (the "Units") under a registered public ...
(Date:7/29/2015)... --  Turing Pharmaceuticals AG announced today that ... its first Chief Communication Officer. In this ... internal and external communications and will provide counsel to ... to Founder and Chairman, Martin Shkreli , and ... "We are excited to have Craig join Turing and ...
Breaking Medicine Technology:Sleep Apnea Devices Market Worth $5.3 Billion by 2020 2Sleep Apnea Devices Market Worth $5.3 Billion by 2020 3Sleep Apnea Devices Market Worth $5.3 Billion by 2020 4Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 3
... and ... additional safety studies, LEVERKUSEN, Germany and WEST HAVEN, Conn., ... the Drug,Safety and Risk Management Advisory Committee to the U.S. Food ... profile of,Trasylol(R) (aprotinin injection), a Bayer drug used in coronary artery,bypass ...
... STEWARTVILLE, Minn., Sept. 12 Rochester,Medical Corporation ... publication of,results from a significant clinical study ... proprietary Infection Control Technology. The newly ... Internal Medicine",presents results of a randomized, double-blind, ...
Cached Medicine Technology:FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R) 2FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R) 3Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial 2Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial 3
(Date:7/29/2015)... , ... July 29, 2015 , ... Andrzej Klos, M.D., ... Klos, a board-certified pediatrician for nearly 38 years, is motivated each and every day ... commitment to his profession shine alongside his many awards and accolades, which include multiple ...
(Date:7/29/2015)... ... July 29, 2015 , ... Gender minority people ... 2012, Massachusetts law has provided legal protections against discrimination on the basis of ... not protect against discrimination based on gender identity in places open to the ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... paper, Our Best Shot: Expanding Prevention through Vaccination in Older Adults, that provides ... offers recommendations on how industry, government, and health care experts can improve patient ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the The Media Post ... are exposed to advertisements, for medicinal use are more likely to abuse the substance. ... use of marijuana is considered beneficial are more apt to use the substance, as ...
(Date:7/29/2015)... ... July 29, 2015 , ... " Core Organizer ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... this app will help anyone get organized. , Wouldn’t it be great if everyone ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Get More Organized with the Core Organizer App 2
... the innovative and diverse approaches that investigators are taking ... clinical evaluation and in early clinical studies. These range ... of more sensitive and specific biomarkers and to data ... prior to commitment of major clinical resources." Mitchell ...
... HealthDay Reporter , MONDAY, May 2 (HealthDay News) ... are larger than the brains of normally developing children, and ... suggests. The finding is a follow-up to earlier research ... than those of similarly aged normally developing kids, researchers said. ...
... Reporter , MONDAY, May 2 (HealthDay News) -- The long-awaited ... Osama bin Laden, comes as a welcome relief to most ... burden of sorrow, and nagging anxieties will remain, mental-health experts ... Massaroli, in the World Trade Center attacks almost 10 years ...
... for Regenerative Medicine (CReM) have demonstrated that induced ... endoderm cells, in vitro, with similar functional potential ... minor molecular differences between the two cell types. ... in the scientific literature about whether subtle differences ...
... People who wash their hands with contaminated soap from ... on their hands and may play a role in ... published in the May issue of the journal ... soap and water is a universally accepted practice for ...
... have discovered that drugs used to treat HIV may ... diseases such as leishmaniasis and malaria. According to ... ( http://www.fasebj.org ), scientists have identified the target of ... kill serious pathogenic parasites. While scientists have long ...
Cached Medicine News:Health News:IMPAKT Breast Cancer Conference 2Health News:Brains of Autistic Kids Still Larger at Age 4, 5 2Health News:Brains of Autistic Kids Still Larger at Age 4, 5 3Health News:Bin Laden's Death Brings Comfort, but Not an End to Anxieties 2Health News:Bin Laden's Death Brings Comfort, but Not an End to Anxieties 3Health News:Boston University researchers validate important roles of iPSCs in regenerative medicine 2Health News:Washing with contaminated soap increases bacteria on hands 2Health News:Scientists show that HIV drugs can also target tropical parasites 2
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
For use with catalog #0540, 0887....
Enzyme Immunoassay of D-Dimer by ELISA Method, 96 tests....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all free...
Medicine Products: